Background Dipeptidyl peptidase-4 inhibitors (DPP-4is) have been reported to exhibit therapeutic effects in Parkinson’s disease (PD), increasing their potential for drug repurposing. One aspect of PD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results